BLU-945 is a reversible, potent, highly selective, and orally available epidermal growth factor receptor tyrosine kinase inhibitor (TKIs). BLU-945 inhibits EGFR phosphorylation in EGFR L858R/T790M/C797S and EGFR ex19del/T790M/C797S mutant cell lines. BLU-945 can be used in lung cancer research, including non-small cell lung cancer (NSCLC).
Molecular Weight:
556.7
Purity:
99.16%
CAS Number:
[2660250-10-0]
Formula:
C28H37FN6O3S
Target:
EGFR
T9754
* VAT and and shipping costs not included. Errors and price changes excepted